Genetic polymorphisms in CYP1A1, GSTM1, GSTP1 and GSTT1 metabolic genes and risk of lung cancer in Asturias

[1]  A. Tardón,et al.  Genetic polymorphisms in CYP1A1, GSTM1, GSTP1 and GSTT1metabolic genes and risk of lung cancer in Asturias , 2012, BMC Cancer.

[2]  A. Tardón,et al.  Educational inequalities in quantity, duration and type of tobacco consumption among lung cancer patients in Asturias: epidemiological analyses. , 2010, Psicothema.

[3]  Neil E. Caporaso,et al.  Lung Cancer and Occupation in a Population-based Case-Control Study , 2010, American journal of epidemiology.

[4]  Jan G. Hengstler,et al.  Susceptibility to urinary bladder cancer: relevance of rs9642880[T], GSTM1 0/0 and occupational exposure. , 2009, Pharmacogenetics and genomics.

[5]  O. Raaschou-Nielsen,et al.  Meta- and pooled analysis of GSTP1 polymorphism and lung cancer: a HuGE-GSEC review. , 2009, American journal of epidemiology.

[6]  A. Tardón,et al.  Polymorphism +17 C/G in Matrix Metalloprotease MMP8 decreases lung cancer risk , 2008, BMC Cancer.

[7]  A. Tardón,et al.  The TP53 Arg72Pro polymorphism and lung cancer risk in a population of Northern Spain. , 2008, Lung cancer.

[8]  E. D. De Capitani,et al.  Influence of p53 codon 72 exon 4, GSTM1, GSTT1 and GSTP1*B polymorphisms in lung cancer risk in a Brazilian population. , 2008, Lung cancer.

[9]  D. Campa,et al.  A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers. , 2008, Carcinogenesis.

[10]  J. Yokota,et al.  CYP1A1, GSTM1, and GSTT1 Polymorphisms, Smoking, and Lung Cancer Risk in a Pooled Analysis among Asian Populations , 2008, Cancer Epidemiology Biomarkers & Prevention.

[11]  A. Tardón,et al.  Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of Northern Spain , 2007, BMC Cancer.

[12]  A. Tjønneland,et al.  Interactions between GSTM1, GSTT1 and GSTP1 polymorphisms and smoking and intake of fruit and vegetables in relation to lung cancer. , 2007, Lung cancer.

[13]  M. Spitz,et al.  Meta- and pooled analysis of GSTT1 and lung cancer: a HuGE-GSEC review. , 2006, American journal of epidemiology.

[14]  J. Fraumeni,et al.  Cancer epidemiology and prevention. , 2006 .

[15]  J. Danesh,et al.  Methods and Findings , 2022 .

[16]  P. Zimmerman,et al.  CYP1A1 Ile462Val and MPO G-463A interact to increase risk of adenocarcinoma but not squamous cell carcinoma of the lung. , 2006, Carcinogenesis.

[17]  Xifeng Wu,et al.  Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study. , 2005, Mutation research.

[18]  D. Schwartz,et al.  CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. , 2005, Carcinogenesis.

[19]  K. Overvad,et al.  Polymorphisms in genes involved in xenobiotic metabolism and lung cancer risk under the age of 60 years. A pooled study of lung cancer patients in Denmark and Norway. , 2005, Lung cancer.

[20]  Bin Zhao,et al.  CYP1A1 polymorphisms and risk of lung cancer in non-smoking Chinese women: influence of environmental tobacco smoke exposure and GSTM1/T1 genetic variation , 2005, Cancer Causes & Control.

[21]  S. Kardia,et al.  Combinations of glutathione S-transferase genotypes and risk of early-onset lung cancer in Caucasians and African Americans: a population-based study. , 2005, Carcinogenesis.

[22]  A. Tardón,et al.  Poly (AT) polymorphism in intron 11 of the XPC DNA repair gene enhances the risk of lung cancer. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[23]  Paolo Boffetta,et al.  Listing Occupational Carcinogens , 2004, Environmental health perspectives.

[24]  P. Brennan,et al.  GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high‐risk population , 2004, International journal of cancer.

[25]  J. Schneider,et al.  GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking. , 2004, Cancer letters.

[26]  P. Vineis,et al.  CYP1A1, GSTM1 and GSTT1 polymorphisms and lung cancer: a pooled analysis of gene–gene interactions , 2004, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[27]  T. Vaughan,et al.  A population-based study of glutathione S-transferase M1, T1 and P1 genotypes and risk for lung cancer. , 2003, Lung cancer.

[28]  P. Vineis,et al.  CYP1A1 T3801 C polymorphism and lung cancer: A pooled analysis of 2,451 cases and 3,358 controls , 2003, International journal of cancer.

[29]  M. Spitz,et al.  Association between glutathione S-transferase p1 polymorphisms and lung cancer risk in Caucasians: a case-control study. , 2003, Lung cancer.

[30]  C. Ulrich,et al.  Polymorphisms in DNA repair genes and associations with cancer risk. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[31]  L. Ward,et al.  The null genotype of glutathione s-transferase M1 and T1 locus increases the risk for thyroid cancer. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[32]  L. Marchand,et al.  Erratum: Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk (Carcinogenesis (2002) vol. 23 (1343-1350)) , 2002 .

[33]  Q. Ma,et al.  Polymorphism of glutathione S-transferase T1, M1 and P1 genes in a Shanghai population: patients with occupational or non-occupational bladder cancer. , 2002, Biomedical and environmental sciences : BES.

[34]  L. Le Marchand,et al.  Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. , 2002, Carcinogenesis.

[35]  P. Vineis,et al.  Metabolic gene polymorphism frequencies in control populations. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[36]  H. Dienemann,et al.  Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas. , 2001, Pharmacogenetics.

[37]  L. Yin,et al.  Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China. , 2001, Lung cancer.

[38]  L. Richiardi,et al.  [Database of occupations and industrial activities that involve the risk of pulmonary tumors]. , 2001, Epidemiologia e prevenzione.

[39]  S. Landi.  Mammalian class theta GST and differential susceptibility to carcinogens: a review. , 2000, Mutation research.

[40]  C. Harris,et al.  Cancer risk and low-penetrance susceptibility genes in gene-environment interactions. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[41]  F. Levi.  Cancer prevention: epidemiology and perspectives. , 1999, European journal of cancer.

[42]  P. Dayer,et al.  Role of glutathione S-transferase GSTM1, GSTM3, GSTP1 and GSTT1 genotypes in modulating susceptibility to smoking-related lung cancer. , 1998, Pharmacogenetics.

[43]  W. Ahrens,et al.  A standard tool for the analysis of occupational lung cancer in epidemiologic studies. , 1998, International journal of occupational and environmental health.

[44]  S. Anttila,et al.  Combined effect of polymorphic GST genes on individual susceptibility to lung cancer , 1998, International journal of cancer.

[45]  I. M. Jones,et al.  Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation? , 1998, Mutation research.

[46]  A. Seidel,et al.  Differences in the catalytic efficiencies of allelic variants of glutathione transferase P1-1 towards carcinogenic diol epoxides of polycyclic aromatic hydrocarbons. , 1998, Carcinogenesis.

[47]  G. B. Smith,et al.  Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. , 1998, Carcinogenesis.

[48]  A. Andersen,et al.  Occupation , 1997, Cancer Causes & Control.

[49]  T. Rebbeck.  Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[50]  S. Srivastava,et al.  Mechanism of differential catalytic efficiency of two polymorphic forms of human glutathione S-transferase P1-1 in the glutathione conjugation of carcinogenic diol epoxide of chrysene. , 1997, Archives of biochemistry and biophysics.

[51]  Jun-yan Hong,et al.  Genetic polymorphism of cytochrome P450 as a biomarker of susceptibility to environmental toxicity. , 1997, Environmental health perspectives.

[52]  J. Buolamwini,et al.  Molecular Cloning, Characterization, and Expression in Escherichia coli of Full-length cDNAs of Three Human Glutathione S-Transferase Pi Gene Variants , 1997, The Journal of Biological Chemistry.

[53]  R. Kaiser,et al.  Polymorphic enzymes of xenobiotic metabolism as modulators of acquired P53 mutations in bladder cancer. , 1996, Pharmacogenetics.

[54]  A. Zuckerman,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.

[55]  K. Nakachi,et al.  PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 gene. , 1991, Nucleic acids research.

[56]  K. Nakachi,et al.  Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. , 1991, Journal of biochemistry.

[57]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[58]  F. Wolf.  Meta-Analysis: Quantitative Methods for Research Synthesis , 1987 .

[59]  Budget,et al.  Standard Industrial Classification Manual , 1987 .

[60]  J. Knowelden,et al.  Cancer Epidemiology and Prevention , 1976, British Journal of Cancer.

[61]  W. Montorsi.  [Cancer of the lung]. , 1975, Minerva medica.

[62]  I. Todd,et al.  Bronchial Carcinoma , 1930, Edinburgh Medical Journal.

[63]  J A TAIANA,et al.  [Cancer of the lung]. , 1952, The Journal of the International College of Surgeons.

[64]  Robert Edwards,et al.  Glutathione Transferases , 2010, The arabidopsis book.

[65]  Pier Alberto Bertazzi,et al.  Exposure to occupational carcinogens and lung cancer risk. Evolution of epidemiological estimates of attributable fraction. , 2008, Acta bio-medica : Atenei Parmensis.

[66]  E. Reszka,et al.  Significance of genetic polymorphisms in glutathione S-transferase multigene family and lung cancer risk. , 2001, International journal of occupational medicine and environmental health.

[67]  H. Bartsch,et al.  Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[68]  J. Hayes,et al.  The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. , 1995, Critical reviews in biochemistry and molecular biology.

[69]  D. Bleyl,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Overall Evaluations of Carcinogenicity: An Updating of IARC Monographs vol. 1 to 42. Supplement 7. 440 Seiten. International Agency for Research on Cancer, Lyon 1987. Preis: 65, – s.Fr , 1989 .